Concerning medication, T1D patients were logically treated with insulins: 47 patients were treated with fast-acting insulins (Anatomical Therapeutic Chemical code /ATC/ A10AB), and 22 of them with long-acting insulins (A10AE) using different commercially available insulin pumps. This evidence concerns the gene INS and type 1 diabetes mellitus.